|1.||Zorlu, Ferruh: 1 article (05/2006)|
|2.||Yildirim, Umit: 1 article (05/2006)|
|3.||Ozen, Haluk: 1 article (05/2006)|
|4.||Divrik, Rauf Taner: 1 article (05/2006)|
|5.||Pfister, Roswell R: 1 article (10/2004)|
|6.||Ma, Wei: 1 article (11/2002)|
|7.||Lu, Jie: 1 article (11/2002)|
|8.||Mao, Xiang: 1 article (11/2002)|
|9.||Qin, Zhong-Jun: 1 article (11/2002)|
|10.||Zhao, Guo-Ping: 1 article (11/2002)|
|1.||Lung Neoplasms (Lung Cancer)
06/01/1987 - "In order to compare the antitumor effect of bleomycin (BLM) administered by continuous subcutaneous infusion (CSI) with that of BLM given by intravenous infusion (IVI), 34 patients with lung cancer metastatic from the cervix were entered into this study after being treated with a combination of bleomycin and mitomycin (B-M). "
05/01/2006 - "The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial."
11/01/2002 - "Streptoverticillum caespitosus ATCC27422 is a producing strain of mitomycin A for cancer therapy. "
05/01/1992 - "Experimental tumor inhibitory and toxic properties of the mitomycin A analogue 7-(2-hydroxyethoxy) mitosane (BMY-25551)."
07/01/1991 - "These correlations are in contrast to those made in the P388 leukemia assay in mice wherein the most active mitomycin C and mitomycin A analogues were the most hydrophilic ones. "
06/01/1977 - "Mitomycin A, mitomycin C, and N-methylmitomycin A were active against P388 leukemia in mice."
|1.||Vinblastine (Vinblastine Sulfate)
|3.||Combination Drug Therapy (Combination Chemotherapy)